Improved health-related quality of life after hepatitis C viraemic clearance among people who inject drugs may not be durable

Original research
par
McDonald, Scott A. et al

Date de publication

2023

Géographie

UK

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

This study aimed to assess the impact of direct-acting antiviral (DAA) treatment success on quality of life (QoL) for people who inject drugs (PWID).

Constatations/points à retenir

Successful direct-acting antiviral therapy for hepatitis C infection may not lead to a durable improvement in quality of life among people who inject drugs, although there may be a transient improvement around the time of sustained virologic response.

La conception ou méthodologie de recherche

Cross sectional study (n=4009) and longitudinal study (n=83)

Mots clés

About PWUD
Injecting drugs
Wrap-around services
Outcomes